Getting an early head start on treating multiple sclerosis (MS) may bring dividends years down the road, find a new study published [...]
Primary progressive multiple sclerosis (PPMS) is an uncommon form of MS that affects approximately 10-15% of MS patients. In PPMS, [...]
For patients with multiple sclerosis (MS), magnetic resonance imaging (MRI) and clinical assessments do not appear to offer long-term [...]
A review article published in the British Journal of Pharmacology assesses antioxidant approaches for treating neurodegenerative [...]
Women with multiple sclerosis (MS) and people diagnosed with the disease at a younger age are more likely to have a benign course of MS, [...]
Therapy for multiple sclerosis (MS) has been on a roll. Since 2009, a steady stream of more effective medications has been introduced for [...]
Multiple sclerosis (MS) risk is higher in children and adolescents with type 1 diabetes, according to research. Susanne Bechtold, M.D., a [...]
In a new study published in the journal Nature Communications, researchers at the University of Bristol claim that the diseases could be [...]
Inflammation in a brain region called the hippocampus might explain why patients with multiple sclerosis (MS) suffer from depression far [...]
